Kite, A Gilead Company
Clinical trials sponsored by Kite, A Gilead Company, explained in plain language.
-
New CAR T-Cell therapy shows promise for tough blood cancers
Disease control OngoingThis study tests a treatment called KTE-X19, a type of cell therapy that uses a patient's own immune cells to fight cancer. It is for Japanese adults with two types of blood cancer that have come back or not responded to other treatments: mantle cell lymphoma and B-cell acute lym…
Phase: PHASE2 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC
-
New cell therapy trial hopes to tame Hard-to-Treat blood cancer
Disease control OngoingThis early-phase study tests experimental cell therapies in 40 people with multiple myeloma that has returned or stopped responding to standard treatments. The main goals are to check safety and find the best dose. Participants must have tried at least three prior therapies. This…
Phase: PHASE1 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC